STOCK TITAN

Director at Alkami Technology (ALKT) receives 11,357 RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ALKAMI TECHNOLOGY, INC. director Charles Kane reported an equity award on Form 4. He received a grant of 11,357 restricted stock units (RSUs) of common stock at no cash purchase price, classified as a grant or award acquisition. These RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before the next Annual Meeting following the grant date. Each RSU represents a contingent right to receive one share of common stock, and Kane has elected to defer receipt of these shares under the company’s 2021 Incentive Plan. Following this award, his directly held stake reported in the filing is 54,646 shares/RSUs.

Positive

  • None.

Negative

  • None.
Insider KANE CHARLES
Role null
Type Security Shares Price Value
Grant/Award Common Stock 11,357 $0.00 --
Holdings After Transaction: Common Stock — 54,646 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSUs granted 11,357 RSUs Grant of restricted stock units to director Charles Kane
Holdings after transaction 54,646 shares/RSUs Total direct holdings following the RSU award
Transaction price per share $0.00 per share Equity award granted at no cash purchase price
Vesting trigger 1 First anniversary of grant date RSUs vest in full on this date if earlier condition not met
Vesting trigger 2 Immediately before Annual Meeting Alternative vesting date following the grant
RSU-to-share ratio 1 RSU = 1 share Each RSU represents a contingent right to one share
restricted stock units (RSUs) financial
"Represents restricted stock units (RSUs) which vest in full on the earlier..."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Annual Meeting financial
"on the earlier of (i) the first anniversary... and (ii) immediately before the Annual Meeting..."
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
contingent right financial
"Each RSU represents a contingent right to receive one share of common stock."
2021 Incentive Plan financial
"under the terms of the 2021 Incentive Plan."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KANE CHARLES

(Last)(First)(Middle)
C/O ALKAMI TECHNOLOGY, INC.
5601 GRANITE PARKWAY, SUITE 120

(Street)
PLANO TEXAS 75024

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ALKAMI TECHNOLOGY, INC. [ ALKT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/19/2026A11,357(1)A$054,646D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units (RSUs) which vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date. Each RSU represents a contingent right to receive one share of common stock. The reporting person elected to defer receipt of these shares under the terms of the 2021 Incentive Plan.
Remarks:
/s/ Douglas A. Linebarger, as Attorney-in-Fact for Charles Kane05/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Alkami (ALKT) director Charles Kane report?

Charles Kane reported receiving an equity award of 11,357 restricted stock units (RSUs) of Alkami common stock. The award was recorded as a grant or other acquisition with no cash purchase price, reflecting standard director compensation rather than an open-market share purchase or sale.

How many Alkami (ALKT) RSUs were granted to Charles Kane and on what terms?

Charles Kane was granted 11,357 restricted stock units (RSUs) of Alkami common stock. These RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before the next Annual Meeting, aligning the award with the company’s annual director service cycle.

Did Charles Kane buy or sell Alkami (ALKT) shares in the open market?

No open-market buy or sell occurred in this filing. The Form 4 shows a grant of 11,357 restricted stock units as compensation, coded as an award acquisition. The transaction price per share is reported as zero, indicating no market purchase or sale took place.

What is Charles Kane’s Alkami (ALKT) ownership after the RSU grant?

After the reported RSU grant, Charles Kane’s direct holdings total 54,646 shares or share-equivalent units. This figure includes the newly awarded restricted stock units, which each represent a contingent right to receive one share of Alkami common stock upon vesting and settlement.

When will Charles Kane’s Alkami (ALKT) RSUs vest according to the filing?

The RSUs granted to Charles Kane vest in full on the earlier of two dates: the first anniversary of the grant date or immediately before the Annual Meeting that follows the grant date. This structure is typical for director equity awards tied to one-year board service terms.

What does it mean that Charles Kane deferred receipt of Alkami (ALKT) shares?

Deferring receipt means Kane chose to postpone taking delivery of the shares underlying his RSUs. Under Alkami’s 2021 Incentive Plan, he elected to defer settlement, so he currently holds a contingent right to receive the shares rather than immediate common stock ownership.